‘Warmer Together’: Moncler Celebrates Warmth and Love, With Legendary Friends Al Pacino and Robert De Niro
15.10.2025 15:00:00 EEST | Business Wire | Press release
Over seven extraordinary decades of evolution and innovation, Moncler has become synonymous with warmth, embracing the elements, and year-round performance and style. It’s true the brand was born in the Alps in 1952 with a mission to protect climbers and mountain workers from the extreme cold, but for Moncler, warmth was never about the outside.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015925807/en/
Al Pacino and Robert De Niro star in Moncler’s Warmer Together campaign. Courtesy of Moncler
To manifest that essence, Moncler today unveils the new global statement, Warmer Together, bringing Al Pacino and Robert De Niro together for their first-ever shared campaign.
Warmer Together goes beyond words, it is the heartbeat of Moncler’s purpose. From the very beginning, the brand has known that true warmth is never only in the jackets we wear, it comes from within. It is the warmth of showing up, of looking out for one another, of staying close even in the coldest places. Moncler stands for more than protection from the elements; it stands for connection. Warmer Together is woven into every stitch, a quiet promise to bring people closer, to build bonds, and to remind us that warmth goes beyond insulation. Real warmth is never solitary, it is real when it is shared.
“For decades, Moncler has been associated with winter and puffer jackets, but I have always felt that Moncler is about something deeper: love and a sense of togetherness.
These values have shaped everything we’ve done for over 70 years. Across every product and every campaign, there runs a consistent thread of emotion and human connection.
Through their story of friendship, Al Pacino and Robert De Niro embody everything Moncler truly stands for: affection, warmth, and the belief that we are all better and warmer together.” Remo Ruffini, Chairman and CEO of Moncler
Shot in New York by world-renowned portrait photographer Platon, the Al Pacino and Robert De Niro story unfolds in striking black-and-white images and a suite of short films cut to five themes — Friendship, Respect, Connection, Trust, Warmth — complete with behind-the-scenes moments and the city’s skyline as a recurring motif. Their mutual bond as friends is evident. As they sit together and speak, each man’s energy lifts the other’s presence.
“Warmth was never about the outside. It was always about what was happening on the inside.” So says Robert De Niro in a teaser released ahead of the launch to share the Warmer Together manifesto.
“Friendship is the greatest thing you can have. Friends, people whom you share the same world with. There is just an innate trust. And the understanding of life.” Al Pacino
Moncler is proud to connect with these two great friends, and two greats of cinema, to share its enduring belief in human warmth. Starting today, Moncler brings Warmer Together to life globally across outdoor, press, web and social, followed by a second wave of films and behind-the-scenes moments in the days after.
To accompany Warmer Together, artist and Moncler ambassador Tobe Nwigwe, together with his wife Fat, has recorded a new rendition of Bill Withers’ classic track Lean on Me. A timeless anthem of friendship, support, and solidarity in challenging times, the song’s lyrics echo the campaign’s message of comfort found in companionship. Its accompanying film reflects the campaign’s cinematic spirit and New York backdrop.
Warmth was never about the outside.
It was always about what was happening on the inside.
Warmth comes from the walks and the talks.
From pulling up a chair and having a chat. The caring conversations.
More than the weather,
warmth is, and will always be, about being together,
no matter what.
Warmer Together
Warmer Together Campaign Manifesto
Warmer in the Moncler Maya 70 and Bretagne Jackets
Embodying timeless warmth, Robert De Niro wears the Maya 70 jacket in the Warmer Together campaign, a modern rendition of the original, down-quilted hero jacket and one of the brand’s most iconic and enduring designs. Whether worn for decades or newly discovered, Maya remains a timeless wardrobe staple, deeply embedded in Moncler’s mountain DNA. Crafted from the brand’s signature longue saison recycled nylon, the design’s defining features include a signature logo-adorned pocket on the left sleeve and a detachable hood.
Showcasing the brand’s constant evolution, while remaining true to its roots, the season sheds a spotlight on the Bretagne jacket. New for Fall/Winter 2025, the short, hooded puffer delivers exceptional protection from the elements without sacrificing comfort or freedom of movement. Designed to provide warmth without weight in a cocooning silhouette, the Bretagne is a versatile actor, perfectly suited for outdoor city scenes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251015925807/en/
Contacts
monclerpress@moncler.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom